Novartis Archives - DelveInsight

Novartis

top-pharma-biotech-companies-by-revenue-share-drugs-therapies-2020-2021-worldwide
Top 7 Pharma Industry Leaders in 2020 By the Numbers

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutic...


Diabetic Macular Edema Market | Diabetic Macular Edema Drug Portfolio
Diabetic Macular Edema Therapy Market to Witness Significant Impact in the Foreseeable Future

Diabetes is a condition in which the blood glucose (blood sugar) level is abnormally high. Glucose, which is obtained from the food consumed, is the primary source of energy in the body. However, ...


Presbyopia Treatment Market | Novartis | Visus | AbbVie
How will Pharmacotherapies help the growing number of Presbyopes?

Presbyopia is the gradual loss of near-focusing ability that occurs with age—a condition that occurs when people get older and prevails as a quite common one in many individuals. The reasons for t...


recent-pharma-news-updates-for-artios-scholar-rock-novavax-volastra
Artios collaborates with Novartis; Scholar Rock eyes Phase III trial; Novavax starts crossover ar...

Artios Pharma announces collaboration with Novartis to tap next-generation DDR cancer therapies Artios Pharma Limited, a leading DNA Damage Response (DDR) company exploiting synthetic lethality...


chimeric-antigen-receptor-therapies-in-blood-cancers
A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in B...

Chimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evolved as a game-changer i...


recent-pharma-happenings-for-asher-bio-roche-novartis-epimab
Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand ...

Asher Bio raises USD 55 Million in Series A financing Asher Biotherapeutics, a biotechnology company developing exactly targeted immunotherapies for cancer and other diseases, raised USD 55 Mil...


Gene and Cell Therapies in CNS Disorders
Gene and Cell Therapies in CNS Disorders: Miracle Cure? Opportunities Galore!

CNS disorders are a wide-ranging set of disorders in which the brain loses its normal functioning, limiting everyday ability to function. These may arise from various reasons-some are inherited, s...


Rare diseases challenges | Rare diseases clinical trials, incidence, and funding
The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of prevalence or incidence o...


recent-pharma-news-and-updates
Birinapant licensing; AvantGen, IGM pairs up for anti-SARS-CoV-2 antibodies; BeiGene, Novartis to...

Medivir, IGM Biosciences enters into an exclusive licensing agreement for Birinapant Medivir AB has entered into an exclusive licensing agreement with IGM Biosciences to receive global, exclusi...


Atsena raises $55M; Neuron23’s strategy for CNS disorders; and more
Mitochondria destruction for Cancer Treatment; Atsena raises USD 55 Million financings; Novartis ...

Mitochondria destruction can help in Cancer Treatment  Human cells require structures known as mitochondria for the generation of energy for their biochemical activities. Researchers at the Kar...


Editor's Pick
Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU ...

Patent protection and expiration is one of the hot topics in the healthcare industry. P...

What are the Top 9 Most Common Food Allergies and How Pharma Companies are Ta...

Food Allergies is a major concern for a wide spectrum of populations globally. Accordin...

Evaluating the Top Players in the Global Bone Densitometers Market

Bone densitometers are the diagnostic systems with an enhanced X-ray technology known a...

Mapping the Biggest Pharmaceutical Companies by Continents

Today, the most important factor affecting the world’s economy is the Global Pharmaceut...

Robotic Surgery: Navigating the Growing Demand, Ongoing Trends & Develop...

It's no longer startling to learn that the best-performing surgeon at a hospital isn't ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.